Immuron (IMRN) Plans Public Offering of ADSs

July 16, 2019 4:32 PM

Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the treatment of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found